|
2025
|
P/S
|
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders |
|
|
P/S
|
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. |
|
|
P/S
|
Pharmaceutical preparations and pharmaceutical products for
use in oncology diseases and disorders. |
|
2024
|
Invention
|
Heteroaromatic macrocyclic ether compounds and isotopologues thereof. Provided herein are heteroa... |
|
|
Invention
|
Heteroaromatic macrocyclic ether compounds. Provided herein are certain heteroaromatic macrocycli... |
|
|
Invention
|
Heteroaromatic macrocyclic ether chemotherapeutic agents.
Disclosed are heterocyclic heteroaroma... |
|
|
Invention
|
Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether comp... |
|
|
Invention
|
Amino-substituted heterocycles for treating cancers with egfr mutations.
Disclosed are amino-sub... |
|
2023
|
Invention
|
Heteroaromatic macrocyclic ether chemotherapeutic agents. The application relates to heterocyclic... |
|
|
Invention
|
Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,... |
|
2022
|
Invention
|
Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds.
Provided herei... |
|
|
Invention
|
Methods of treating solid tumor using heteroaromatic macrocyclic ether compounds. Provided herein... |
|
|
Invention
|
Heteroaromatic macrocyclic ether chemotherapeutic agents. Disclosed are heterocyclic heteroaromat... |
|
|
Invention
|
Amino-substituted heteroaryls for treating cancers with egfr mutations. Disclosed are amino-subst... |
|
|
Invention
|
Amino-substituted heterocycles for treating cancers with egfr mutations. Disclosed are amino-subs... |
|
2021
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
